Completed PHASE3 INTERVENTIONAL 2-arm NCT00821353

Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy

Sinus Rhythm Maintenance in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation - Randomized Comparison of Antiarrhythmic Therapy vs. Radiofrequency Catheter Ablation (SHAARC)

Sponsor: National Institute of Cardiology, Warsaw, Poland

Conditions Atrial Fibrillation Hypertrophic Cardiomyopathy

Interventions Antiarrhythmic drugs RF catheter ablation

Updated 6 times since 2017 Last updated: Feb 4, 2013 Started: Jan 31, 2009 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Atrial Fibrillation and Hypertrophic Cardiomyopathy, this trial is completed. The trial is conducted by National Institute of Cardiology, Warsaw, Poland and has accumulated 6 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
May 2023 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — May 2023 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Cardiology, Warsaw, Poland

Data source: National Institute of Cardiology, Warsaw, Poland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland